Cargando…
Meta-analysis of the safety of voriconazole in definitive, empirical, and prophylactic therapies for invasive fungal infections
BACKGROUND: Voriconazole has been used in the treatment and prophylaxis of invasive fungal infections (IFIs) while its wide use was limited by some frequent adverse events, especially neurotoxicity, hepatotoxicity and even renal disruption. The aim of this study was to comprehensively compare vorico...
Autores principales: | Xing, Yuanming, Chen, Lu, Feng, Yan, Zhou, Yan, Zhai, Yajing, Lu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745890/ https://www.ncbi.nlm.nih.gov/pubmed/29281997 http://dx.doi.org/10.1186/s12879-017-2913-8 |
Ejemplares similares
-
Voriconazole in the management of nosocomial invasive fungal infections
por: Pemán, Javier, et al.
Publicado: (2006) -
Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey
por: Turner, Stuart J, et al.
Publicado: (2013) -
Voriconazole is a safe and effective anti-fungal prophylactic agent during induction therapy of acute myeloid leukemia
por: Shah, Akash, et al.
Publicado: (2016) -
Update on the optimal use of voriconazole for invasive fungal infections
por: Lat, Asma, et al.
Publicado: (2011) -
Therapeutic drug monitoring and safety evaluation of voriconazole in
the treatment of pulmonary fungal diseases
por: Shen, Kunlu, et al.
Publicado: (2022)